MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, COAG has $175,258K in assets. $13,708K in debts. $49,860K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1284.64%
Quick Ratio
1284.64%
Cash Ratio
378.04%
Debt to Asset Ratio
7.82%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Other non-current assets
    • Operating right-of-use assets
Liabilities Breakdown
    • Accumulated deficit
    • Preferred stock value-Series CCo...
    • Preferred stock value-Series BCo...
    • Others

Balance Sheets
2026-03-31
Cash and cash equivalents
49,860
Marketable securities
113,671
Prepaid expenses and other current assets
5,900
Total current assets
169,431
Property and equipment, net
648
Operating right-of-use assets
939
Other non-current assets
4,240
Total assets
175,258
Accounts payable
5,682
Accrued expenses and other current liabilities
6,963
Operating lease liabilities
544
Total current liabilities
13,189
Operating lease liabilities, net of current portion
519
Total liabilities
13,708
Preferred stock value-Series Seed Convertible Preference Shares And Convertible Preferred Stock
5,236
Preferred stock value-Series AConvertible Preference Shares And Convertible Preferred Stock
63,536
Preferred stock value-Series BConvertible Preference Shares And Convertible Preferred Stock
134,975
Preferred stock value-Series CConvertible Preference Shares And Convertible Preferred Stock
156,421
Stockholders' deficit-Ordinary Shares
0
Stockholders' deficit-Common Stock
0
Additional paid in capital
6,366
Accumulated other comprehensive (loss) income
-439
Accumulated deficit
-204,545
Total stockholders' deficit
-198,618
Total liabilities, convertible preference shares, convertible preferred stock and stockholders' deficit
175,258
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$113,671K Cash and cashequivalents$49,860K Prepaid expenses andother current assets$5,900K Total current assets$169,431K Other non-currentassets$4,240K Operating right-of-useassets$939K Property and equipment,net$648K Total assets$175,258K Accumulated deficit-$204,545K Accumulated othercomprehensive (loss) income-$439K Total liabilities,convertible preference...$175,258K Total stockholders'deficit-$198,618K Additional paid in capital$6,366K Preferred stockvalue-Series CConvertible...$156,421K Preferred stockvalue-Series BConvertible...$134,975K Preferred stockvalue-Series AConvertible...$63,536K Total liabilities$13,708K Preferred stockvalue-Series Seed...$5,236K Total currentliabilities$13,189K Operating leaseliabilities, net of current...$519K Accrued expenses andother current...$6,963K Accounts payable$5,682K Operating leaseliabilities$544K

Hemab Therapeutics Holdings, Inc. (COAG)

Hemab Therapeutics Holdings, Inc. (COAG)